Evidence map›Paper›PMID 1650477›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1991

Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol.

P R Skolnik, B Jahn, M Z Wang, T R Rota, M S Hirsch, S M Krane

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Counter-intuitive plasma vitamin D and zinc status in HIV-1-infected adults with persistent low-level viraemia after treatment initiation: a pilot case-control study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  5. Article
  6. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  7. Article
  8. Article
  9. Article
  10. Nutrition and HIV infection in children.Indian journal of pediatrics
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

P R SkolnikDepartment of Medicine, Tufts University School of Medicine, Boston, MA.
B Jahn
M Z Wang
T R Rota
M S Hirsch
S M Krane

Funding

STUDY OF MESENCHYMAL TISSUES &THEIR DISEASESP01AR003564 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI GOLDRING, STEVEN REYBURN · 1986 to 1997
–
IMMUNE REACTIVITY AND ONCOGENIC VIRUS INFECTIONSR01CA012464 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HIRSCH, MARTIN S. · 1985 to 1999
–
VIRUSES, ACQUIRED IMMUNODEFICIENCY, AND KAPOSI'S SARCOMAR01CA035020 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HIRSCH, MARTIN S. · 1986 to 1993
–
VIRUSES ACQUIRED IMMUNODEFICIENCY AND KAPOSI SARCOMAU01CA035020 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HIRSCH, MARTIN S. · 1985 to 1985
–
NCI NIH HHS CA-12464NCI NIH HHS CA-35020NIAMS NIH HHS AR-03564
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) expression and replication are under tight regulatory control. We demonstrate that 1,25-dihydroxycholecalciferol [1,25-(OH)2D3] enhances the replication of monocyte- and lymphocyte-tropic strains of HIV-1 up to 10,000-fold in monocyte cell lines, peripheral blood monocytes, and unfractionated peripheral blood mononuclear cells. 1,25(OH)2D3 is therefore one of the most potent regulators of HIV-1 replication described to date. Precursors of 1,25(OH)2D3 enhance HIV-1 replication in proportion to their affinity for the 1,25(OH)2D3 intracellular receptor, suggesting that 1,25(OH)2D3 influences HIV-1 replication by mechanisms involving this receptor. These studies may have important implications for the design of effective therapy of HIV-1 infection.

Indexed as

Antigens, CDBone MarrowCalcitriolCell LineGene Products, gagHIV-1HIV Core Protein p24HLA-DR AntigensHumansKineticsMonocytesReceptors, CalcitriolReceptors, SteroidViral Core ProteinsVirus ReplicationAntigens, CDCalcitriolGene Products, gagHIV Core Protein p24HLA-DR AntigensReceptors, CalcitriolReceptors, SteroidViral Core Proteins

Identifiers

PMID1650477
PMCPMC52142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.